Skip to main content
. 2020 Jun 30;10:1065. doi: 10.3389/fonc.2020.01065

Figure 2.

Figure 2

Diagram of the Data Analysis Plan (DAP), originally developed within the FDA-led MAQC/SEQC-II initiatives. If the training set labels are stochastically shuffled beforehand, the DAP runs in “random labels” mode as a sanity check to ensure that the procedure is not affected by systematic bias.